tiprankstipranks
Trending News
More News >
Park Ha Biological Technology Co., Ltd. (PHH)
:PHH
US Market

Park Ha Biological Technology Co., Ltd. (PHH) Ratios

Compare
7 Followers

Park Ha Biological Technology Co., Ltd. Ratios

PHH's free cash flow for Q2 2018 was $―. For the 2018 fiscal year, PHH's free cash flow was decreased by $ and operating cash flow was $―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.87 1.75 0.96 0.41-
Quick Ratio
1.82 1.67 0.92 0.14-
Cash Ratio
0.36 0.83 0.24 0.06-
Solvency Ratio
0.32 0.70 0.09 -0.38-
Operating Cash Flow Ratio
0.63 0.10 0.61 -0.43-
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00-
Net Current Asset Value
$ 1.27M$ 923.75K$ -103.81K$ -698.81K-
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.01 0.01 0.06-
Debt-to-Equity Ratio
0.05 0.03 0.17 -0.06-
Debt-to-Capital Ratio
0.04 0.03 0.15 -0.06-
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00-
Financial Leverage Ratio
2.05 2.24 16.76 -1.03-
Debt Service Coverage Ratio
0.00 0.00 1.14K -372.49-
Interest Coverage Ratio
0.00 0.00 1.02K -419.58-
Debt to Market Cap
0.00 0.00 0.00 0.00-
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01-
Net Debt to EBITDA
-0.58 -0.83 -2.49 0.08-
Profitability Margins
Gross Profit Margin
91.80%87.35%73.47%66.58%-
EBIT Margin
33.32%48.05%9.91%-51.96%-
EBITDA Margin
34.28%48.82%11.50%-47.77%-
Operating Profit Margin
33.32%48.01%10.26%-53.81%-
Pretax Profit Margin
33.31%48.05%9.90%-52.09%-
Net Profit Margin
20.09%34.65%9.97%-52.09%-
Continuous Operations Profit Margin
20.09%34.65%9.97%-52.09%-
Net Income Per EBT
60.32%72.11%100.68%100.00%-
EBT Per EBIT
99.96%100.09%96.44%96.80%-
Return on Assets (ROA)
15.52%37.62%7.60%-81.61%-
Return on Equity (ROE)
31.78%84.15%127.30%83.88%-
Return on Capital Employed (ROCE)
50.92%115.52%131.11%89.09%-
Return on Invested Capital (ROIC)
30.37%81.55%112.40%92.26%-
Return on Tangible Assets
15.56%37.76%7.62%-81.61%-
Earnings Yield
182656.87%325206.87%73014.50%-0.17%-
Efficiency Ratios
Receivables Turnover
2.15 3.46 1.26 11.68-
Payables Turnover
8.12 1.58 3.92 3.48-
Inventory Turnover
2.73 3.24 5.41 0.98-
Fixed Asset Turnover
13.63 34.91 30.55 8.72-
Asset Turnover
0.77 1.09 0.76 1.57-
Working Capital Turnover Ratio
2.11 5.93 -4.88 0.00-
Cash Conversion Cycle
258.65 -13.38 264.64 297.72-
Days of Sales Outstanding
170.05 105.50 290.13 31.25-
Days of Inventory Outstanding
133.58 112.52 67.51 371.28-
Days of Payables Outstanding
44.97 231.40 92.99 104.80-
Operating Cycle
303.62 218.02 357.63 402.52-
Cash Flow Ratios
Operating Cash Flow Per Share
0.04 <0.01 0.06 -0.02-
Free Cash Flow Per Share
0.03 <0.01 0.05 -0.02-
CapEx Per Share
<0.01 <0.01 <0.01 <0.01-
Free Cash Flow to Operating Cash Flow
0.91 0.82 0.99 1.03-
Dividend Paid and CapEx Coverage Ratio
11.22 5.58 121.30 -38.57-
Capital Expenditure Coverage Ratio
11.22 5.58 121.30 -38.57-
Operating Cash Flow Coverage Ratio
13.66 4.02 55.06 -14.14-
Operating Cash Flow to Sales Ratio
0.40 0.05 0.75 -0.53-
Free Cash Flow Yield
333931.68%39641.60%545960.31%-0.18%-
Valuation Ratios
Price-to-Earnings (P/E) Ratio
<0.01 <0.01 <0.01 -594.28-
Price-to-Sales (P/S) Ratio
<0.01 <0.01 <0.01 309.55-
Price-to-Book (P/B) Ratio
<0.01 <0.01 <0.01 -498.46-
Price-to-Free Cash Flow (P/FCF) Ratio
<0.01 <0.01 <0.01 -564.25-
Price-to-Operating Cash Flow Ratio
<0.01 <0.01 <0.01 -578.88-
Price-to-Earnings Growth (PEG) Ratio
>-0.01 <0.01 >-0.01 0.00-
Price-to-Fair Value
<0.01 <0.01 <0.01 -498.46-
Enterprise Value Multiple
-0.58 -0.83 -2.48 -647.91-
Enterprise Value
EV to EBITDA
-0.58 -0.83 -2.48 -647.91-
EV to Sales
-0.20 -0.41 -0.29 309.51-
EV to Free Cash Flow
-0.55 -9.65 -0.38 -564.18-
EV to Operating Cash Flow
-0.50 -7.92 -0.38 -578.80-
Tangible Book Value Per Share
0.06 0.04 <0.01 -0.02-
Shareholders’ Equity Per Share
0.06 0.04 <0.01 -0.02-
Tax and Other Ratios
Effective Tax Rate
0.40 0.28 >-0.01 0.00-
Revenue Per Share
0.09 0.09 0.07 0.04-
Net Income Per Share
0.02 0.03 <0.01 -0.02-
Tax Burden
0.60 0.72 1.01 1.00-
Interest Burden
1.00 1.00 1.00 1.00-
Research & Development to Revenue
0.02 0.01 0.03 0.00-
SG&A to Revenue
0.34 0.20 0.37 0.81-
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00-
Income Quality
2.01 0.15 7.54 1.03-
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis